Elser Financial Planning Inc Buys Shares of 988 UnitedHealth Group Incorporated $UNH

Key Points

• Elser Financial Planning Inc purchased 988 shares of UnitedHealth Group, valued at approximately $289,000, indicating institutional interest in the healthcare stock.
• Analysts have provided mixed ratings for UnitedHealth Group, with a consensus of "Moderate Buy" and an average price target of $358.95.
• UnitedHealth Group reported a missed earnings estimate in its last quarterly results, with $4.08 EPS compared to the expected $4.45 EPS.

Elser Financial Planning Inc bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 988 shares of the healthcare conglomerate's stock, valued at approximately $289,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC grew its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Cerro Pacific Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Cerro Pacific Wealth Advisors LLC now owns 2,334 shares of the healthcare conglomerate's stock valued at $1,181,000 after purchasing an additional 33 shares in the last quarter. Fifth Third Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 9.9% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 14,772 shares of the healthcare conglomerate's stock worth $7,737,000 after buying an additional 1,332 shares in the last quarter. Finally, Sterneck Capital Management LLC bought a new position in shares of UnitedHealth Group in the 1st quarter valued at about $207,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on UNH. Bank of America lifted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $344.15 on Monday. The company has a market cap of $311.69 billion, a PE ratio of 14.91, a P/E/G ratio of 2.24 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business has a 50-day simple moving average of $301.20 and a two-hundred day simple moving average of $358.73. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the firm posted $6.80 EPS. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.